Company page

Amylyx Pharmaceuticals, Inc.

Amylyx Pharmaceuticals, Inc. (ticker: AMLX) is a public company based in the United States, with a market capitalization of approximately $1.74 billion. The company focuses on developing innovative therapies for neurodegenerative diseases. Amylyx aims to address significant unmet medical needs through its research and development efforts.